TITLE

MEDICATIONS SIDE EFFECTS: WHY THEY OCCUR AND HOW YOU CAN PREVENT THEM

AUTHOR(S)
Cohen, Jay
PUB. DATE
March 2003
SOURCE
Life Extension;Mar2003, Vol. 9 Issue 3, p46
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
States that the use of lower doses of drugs and individual variation minimize the risks of side effects. Determination of the lowest dose that works; Matching of doses to patients' needs; Potency of different statin drugs; Lower initial doses of antihypertensive drugs; Lower medical doses for older people; Lower but effective doses for 36 prescribed drugs.
ACCESSION #
9116439

 

Related Articles

  • The Pediatric Challenge. Sutton, Stephanie // Pharmaceutical Technology;Jun2011, Vol. 35 Issue 6, p14 

    The article discusses the exploration of microdosing which is used to obtain pharmacokinetic data to be used in studying new drugs in the U.S.

  • Treatment of Acute Decompensated Heart Failure: Harmful Effects of High Doses of Loop Diuretics? Andersen, Geir Øystein // Cardiology;2009, Vol. 113 Issue 1, p9 

    The author reflects on the effects of high doses of loop diuretics in treating acute decompensated heart failure (ADHF). He tackles the study of Peacock and colleagues which investigates the association of high-dose diuretics and adverse outcomes. Result shows that patients who received high...

  • Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity. Chun-jun Li; Jing Li; Qiu-mei Zhang; Lin Lv; Rui Chen; Chun-feng Lv; Pei Yu; De-min Yu // Cardiovascular Diabetology;2012, Vol. 11 Issue 1, p142 

    Objective: To assess the efficacy and safety of adding liraglutide to established insulin therapy in poorly controlled Chinese subjects with type 2 diabetes and abdominal obesity compared with increasing insulin dose. Methods: A 12-week, randomized, parallel-group study was carried out. A total...

  • Solving the Medication Adherence Puzzle. Lassen, David; Hermes, Matthew // Benefits & Compensation Digest;Oct2010, Vol. 47 Issue 10, p26 

    The article discusses the efficiency of buying drug supplies on an extended basis, like every three months, for patients to stick on their drug regimens. A November 2009 Prescription Solutions and the National Council on Patient Information and Education survey revealed that 54% of American do...

  • Dalteparin as the Primary Low-Molecular-Weight Heparin on a Hospital Formulary. GOLDMAN, MONICA C. // Connecticut Medicine;Jan2009, Vol. 73 Issue 1, p23 

    The article discusses a study on the use of dalteparin as primary low-molecular weight heparin (LMWH) on a hospital laboratory. A study by C. Kani et al revealed that the half life of such drug was extended with decreased renal function and also with edema and utilization of vasopressor agents....

  • Simplification From Protease Inhibitors to Once- or Twice-Daily Raltegravir: The ODIS Trial. Vispo, Eugenia; Barreiro, Pablo; Maida, Ivana; Mena, Alvaro; Blanco, Francisco; Rodríguez-Novoa, Sonia; Morello, Judit; Jimenez-Nacher, Inmaculada; Gonzalez-Lahoz, Juan; Soriano, Vincent // HIV Clinical Trials;Jul/Aug2010, Vol. 11 Issue 4, p197 

    Background: Raltegravir has demonstrated good antiviral activity and safety profile in twice-daily (bid) dosing. However, its long terminal elimination half-life might allow once-daily (qd) administration. Methods: Consecutive HIV-infected individuals at our clinic under protease inhibitor...

  • Double-blind comparison of half-dose and standard-dose flupenthixol decanoate in the maintenance treatment of stabilised out-patients with schizophrenia. Johnson, D.A.W.; Ludlow, J.M.; Street, K.; Taylor, R.D.W.; Johnson, D A; Taylor, R D // British Journal of Psychiatry;Nov87, Vol. 151, p634 

    A double-blind controlled trial of 50% dose reduction in maintenance treatment in stable out-patients with low BPRS scores and good social function shows a significantly higher relapse rate in the low-dose group at 12 months (P less than 0.05). After an interval of 24-36 months from dose...

  • No harm done. Moore, Alison // Nursing Standard;9/28/2005, Vol. 20 Issue 3, p22 

    People who take a drug overdose or otherwise harm themselves do not always receive a good reception in A&E. But in Kent an award-winning scheme is helping people to avoid the repetition of self-harming behaviour. INSET: Guidance on the treatment of people who self-harm.

  • Prospective studies urged of health risks. Butler, Declan // Nature;3/16/1995, Vol. 374 Issue 6519, p204 

    Highlights a report by the French biomedical research agency INSERM on risks associated with the use of therapeutics of human or animal origin. Social responsibility of fundamental researchers to help clinicians in anticipating such risks. Details of the report.

  • When you go toe-to-toe over doctor's orders. Horsley, Jack; Ventura, Marissa J. // RN;Nov97, Vol. 60 Issue 11, p59 

    States that a physician can be liable if a patient fails to question the physician about an inappropriate order or treatment plan. Reference to a case involving a patient who came to the hospital with symptoms of tuberculosis; Steps to reduce liability.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics